Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2015-09-30
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the last decades a number of specialized psychotherapeutic treatment programs have been developed. Despite their conceptual differences, many of the treatment models have shown significant effects in the treatment of PD in adults. However, the treatment of adolescents with PD remains difficult and further enhancement and development of treatments is needed.
Given the different therapeutic approaches available, the present project aims to go beyond the comparison of integral therapeutic models in the classical outcome study design. While outcome research is important to build on the evidence of the effectiveness of an intervention, it contributes little to its understanding and refinement. The aim of the present multi-center project is to compare two therapeutic methods used in routine care:
* Adolescent Identity Treatment (AIT)
* Dialectic Behavioral Treatment for Adolescents (DBT-A)
Treatments will be performed at different study centers and compared using the same measures of outcome. The main outcome will be psychosocial functioning.
Additionally, the psychotherapy process will be investigated to explore specific and unspecific mechanisms of the therapeutic process, its outcome and mediators.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Integration During Psychiatric Inpatient Therapy as Predictor of Treatment Response
NCT04770038
Efficacy of Time-limited Psychodynamic Psychotherapy and Informed Clinical Management in BPD High MHS Users
NCT01356069
Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT
NCT05289583
The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder
NCT05986552
Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders
NCT00247234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adolescent Identity Treatment
Psychotherapeutic treatment performed routinely at the centres in Basel and Santiago de Chile
Adolescent Identity Treatment
Integrative Approach for the treatment of adolescents with Personality Disorder.
Manual was published in 2013.
DBT-A
Psychotherapeutic treatment performed routinely at the centre in Heidelberg
DBT-A
Dialectic Behavioral Treatment for Adolescents is the most commonly used Approach for the Treatment of adolescents with Boderline Personality Disorder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adolescent Identity Treatment
Integrative Approach for the treatment of adolescents with Personality Disorder.
Manual was published in 2013.
DBT-A
Dialectic Behavioral Treatment for Adolescents is the most commonly used Approach for the Treatment of adolescents with Boderline Personality Disorder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* borderline Criteria (SKID-II)
Exclusion Criteria
* psychotic disorder
* pervasive developmental disorders
* heavy and persistent substance abuse
* major somatic or neurological disease
* hospital treatment
13 Years
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Pontificia Universidad Catolica de Chile
OTHER
Klaus Schmeck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klaus Schmeck
Professor of Child and Adolescent Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Schmeck, Prof.
Role: STUDY_DIRECTOR
University Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Millennium Institute for Research in Depression and Personality - Pontificia Universidad Católica de Chile
Santiago, , Chile
Department of Child and Adolescent Psychiatry, Centre for Psychosocial Medicine, University of Heidelberg
Heidelberg, , Germany
Psychiatric Universitiy Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schmeck K, Weise S, Schluter-Muller S, Birkholzer M, Furer L, Koenig J, Krause M, Lerch S, Schenk N, Valdes N, Zimmermann R, Kaess M. Effectiveness of adolescent identity treatment (AIT) versus DBT-a for the treatment of adolescent borderline personality disorder. Personal Disord. 2023 Mar;14(2):148-160. doi: 10.1037/per0000572. Epub 2022 May 19.
Zimmermann R, Furer L, Schenk N, Koenig J, Roth V, Schluter-Muller S, Kaess M, Schmeck K. Silence in the psychotherapy of adolescents with borderline personality pathology. Personal Disord. 2021 Mar;12(2):160-170. doi: 10.1037/per0000402. Epub 2020 Apr 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EAST
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.